LINC01138 was reported to be an oncogenic driver that accelerates HCC cell proliferation, tumorigenicity, invasion, and metastasis, via interacting with arginine methyltransferase 5 to prevent its ubiquitin/proteasome-dependent degradation. Here, LINC01138 is linked to hepatocellular carcinoma.